Colorectal Cancer Therapeutics Market

Home Healthcare And Pharmaceutical Colorectal Cancer Therapeutics Market

Colorectal Cancer Therapeutics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028, Segmented By Therapy (Target Therapy, Immunotherapy, Chemotherapy, Others); By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others); Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)

Published Date: October 2022
Report ID: BWC22426
Available Format: PDF
Page: 313

Report Overview

High incidences of colorectal cancer across the world, increasing awareness about the disease and high mortality rate associated with the cancer, and the launch of novel therapeutics are expected to drive global colorectal cancer therapeutics market at a significant growth rate during the period in analysis.

Global Colorectal Cancer Therapeutics Market - Industry Trends & Forecast Report, 2028

Global Colorectal Cancer Therapeutics Market size was estimated at USD 12.38 billion in 2021. During the forecast period between 2022 and 2028, global colorectal cancer therapeutics market size is expected to grow at a significant CAGR of 7.4% reaching a value of USD 20.16 billion by 2028. Rising frequency of colorectal cancer and the availability of different treatment options are major growth drivers for global colorectal cancer therapeutics market. Colorectal cancer is a malignant tumor on the inner wall of the large intestine. The cancer is caused by abnormal cell proliferation, which can infiltrate and spread to other parts of the body. The most common causes of colorectal cancer are inflammatory bowel disease and genetic inheritance. Lonsurf, CYRAMZA (ramucirumab), TS-1/Teysuno, CPP-1X (cephaloridine hydrochloride), MelCancerVac, Xilonix, and Nintedanib are some of the colorectal cancer therapies in the development. Colorectal cancer can be treated with a variety of treatments, including chemotherapy agents, immunotherapy, and leucovorin (a chemoprotectant).

Colorectal Therapeutics Market

Global Colorectal Cancer Therapeutics Market – Technology Advancements

Colorectal cancer treatment with therapeutics requires a multifaceted approach, which may necessitate the use of a combination treatment involving several medications. Several key market leaders have introduced advanced drugs to address the diverse treatment needs of colorectal cancer. For example, the implementation of newer initiatives aimed at the effective care of colorectal cancer patients is expected to contribute to global growth. Dana-Farber Cancer Institute, a leading cancer treatment and research institution in the United States, announced the establishment of the Young-Onset Colorectal Cancer Centre in April 2019. Colorectal cancer medications have undergone significant R&D advancements since they were first introduced to the public. Since then, several novel therapeutics have been introduced, with encouraging results. In some ways, the global market may be considered overcrowded due to the presence of several major players and the growing influence of comparatively cheaper generics, particularly in chemotherapy. However, the serious nature of colorectal cancer necessitates the use of cutting-edge therapeutics and the rising prevalence necessitate a better treatment outlook for patients. This has resulted in a significant unmet treatment need in the market, which is expected to be one of the other key driving factors for the global colorectal cancer therapeutics market.

Global Colorectal Cancer Therapeutics Market - Industry Trends and Forecasts

Growth Drivers

Increasing awareness about colorectal cancer and therapeutics

The rise in colorectal cancer awareness is a major element driving the growth of the global colorectal cancer therapeutics market. Furthermore, the increasing number of corresponding product introductions for effective colorectal cancer therapy could aid overall market growth during the period in analysis. Also, the introduction of recent efforts aimed at providing better colorectal cancer patient care could contribute to the growth of the market for colorectal cancer therapeutics. Furthermore, high mortality rates, combined with increased global demand for effective cancer treatments, are expected to boost the growth of the colorectal cancer therapeutics market in during the forecast period.

Restraints

High cost and slow adoption rate of therapeutics

Global colorectal cancer therapeutics market growth could be limited by a lack of knowledge among patient population in emerging countries and under developing economies. There is also significant reluctance among people to adopt colorectal cancer drugs in some regions due its high costs.

Impact of COVID -19 on Global Colorectal Cancer Therapeutics Market

The sudden emergence of the COVID-19 pandemic prompted the imposition of strict lockdown measures across countries, causing delays in the import and export of colorectal cancer therapeutics. The global market for colorectal cancer drugs was estimated to fall with a negative CAGR in 2021. The slow decline is primarily due to the COVID-19 outbreak, which has reduced demand for immunocompromised treatments. However, post pandemic and lockdown relaxations, the market is expected to bounce back its pre Covid-19 growth level.

Segmental Coverage

Global colorectal cancer therapeutics market is segmented by target therapy, cancer type, distribution channel, and region. The target therapy segment is further categorized into immunotherapy, chemotherapy, and others. The global colorectal cancer therapeutics market by cancer type is sub-segmented into colorectal adenocarcinoma, gastrointestinal carcinoid tumors, and others. By distribution channel, the market is further segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. There are five major regions, namely North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, in the global colorectal cancer therapeutics market. Each regional market is further categorized by its major countries.

Regional Insights

Global colorectal cancer therapeutics market by geography is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Because of the rising prevalence of colorectal cancer cases in the region, North America dominates the global market for colorectal cancer therapeutics. Furthermore, the market for colorectal cancer therapeutics in North America is being driven by greater illness awareness and enhanced healthcare infrastructure. Over the next few years, the market for colorectal cancer therapeutics in Asia Pacific (APAC) is forecast to rise rapidly, followed by that in Europe. In the APAC region, China and India could be the fastest expanding markets for colorectal cancer therapeutics.

Competitive Landscape

Prominent players in global colorectal Cancer therapeutics market include Accord Healthcare Ltd., Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Biocon Ltd., Bristol-Myers Squibb Co., CK Hutchison Holdings Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hetero Drugs Ltd., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. These companies follow various strategies, including mergers and acquisitions, joint ventures, partnerships, collaborations, and licensing agreements to further enhance their position in global colorectal cancer therapeutics market.

Recent Developments

In December 2021 - Natco Pharma launched a novel fixed-dose combination of Trifluridine and Tipiracil, used to treat advanced colorectal and gastric cancer, in India.
In December 2021 - the US Food and Drug Administration (US FDA) granted Isofol Medical AB fast track designation for Arfolitixorin (6R-MTHF) for patients with metastatic colorectal cancer.
In June 2021 - Bristol Myers Squibb announced the European Commission approval of Opdivo plus Yervoy for the treatment of adult patients with microsatellite instability-high metastatic colorectal cancer. It has been granted marketing authorization for use in all EU member countries as well as Norway, Iceland, and Liechtenstein.

Scope of the Report

Attributes	Details
Years Considered	Historical Data – 2018–2021
	Base Year – 2021
	Estimated Year – 2022
	Forecast – 2022–2028
Facts Covered	Revenue in USD Billion
Market Coverage	North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific), Latin America (Brazil, Mexico, Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East & Africa)
Product/ Service Segmentation	Therapy, Cancer Type, Distribution Channel, Region
Key Players	Accord Healthcare Ltd., Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Biocon Ltd., Bristol-Myers Squibb Co., CK Hutchison Holdings Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hetero Drugs Ltd., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc.

By Therapy

Target Therapy
Immunotherapy
Chemotherapy
Others

By Cancer Type

Colorectal Adenocarcinoma
Gastrointestinal Carcinoid Tumors
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

By Region

- - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa

Research Framework
1. Research Objective
2. Product Overview
3. Market Segmentation
Research Methodology
1. Qualitative Research
  1. Primary & Secondary Research
2. Quantitative Research
3. Market Breakdown & Data Triangulation
  1. Secondary Research
  2. Primary Research
4. Breakdown of Primary Research Respondents, By Region
5. Assumption & Limitation
Executive Summary
Global Colorectal Cancer Therapeutics Market Insights
1. Industry Value Chain Analysis
2. DROC Analysis
  1. Growth Drivers
  2. Restraints
  3. Opportunities
  4. Challenges
3. Technological Advancement/Recent Development
4. Regulatory Framework
5. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
Global Colorectal Cancer Therapeutics Market Overview
1. Market Size & Forecast by Value, 2018-2028
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Therapy
    1. Target Therapy
    2. Immunotherapy
    3. Chemotherapy
    4. Others
  2. By Cancer Type
    1. Colorectal Adenocarcinoma
    2. Gastrointestinal Carcinoid Tumors
    3. Others
  3. By Distribution Channel
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
    4. Others
  4. By Region
    1. North America
    2. Europe
    3. Asia Pacific
    4. Latin America
    5. The Middle East and Africa
North America Colorectal Cancer Therapeutics Market
1. Market Size & Forecast by Value, 2018-2028
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Therapy
  2. By Cancer Type
  3. By Distribution Channel
  4. By Country
    1. United States
    2. Canada
Europe Colorectal Cancer Therapeutics Market
1. Market Size & Forecast by Value, 2018-2028
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Therapy
  2. By Cancer Type
  3. By Distribution Channel
  4. By Country
    1. Germany
    2. United Kingdom
    3. Italy
    4. France
    5. Spain
    6. The Netherlands
    7. Belgium
    8. NORDIC Countries
    9. Rest of Europe
The Asia Pacific Colorectal Cancer Therapeutics Market
1. Market Size & Forecast by Value, 2018-2028
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Therapy
  2. By Cancer Type
  3. By Distribution Channel
  4. By Country
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Australia & New Zealand
    6. Indonesia
    7. Malaysia
    8. Singapore
    9. Philippines
    10. Vietnam
    11. Rest of Asia Pacific
Latin America Colorectal Cancer Therapeutics Market
1. Market Size & Forecast by Value, 2018-2028
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Therapy
  2. By Cancer Type
  3. By Distribution Channel
  4. By Country
    1. Brazil
    2. Mexico
    3. Argentina
    4. Peru
    5. Columbia
    6. Rest of Latin America
The Middle East & Africa Colorectal Cancer Therapeutics Market
1. Market Size & Forecast by Value, 2018-2028
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Therapy
  2. By Cancer Type
  3. By Distribution Channel
  4. By Country
    1. Saudi Arabia
    2. UAE
    3. South Africa
    4. Qatar
    5. Kuwait
    6. Iran
    7. Nigeria
    8. Kenya
    9. Egypt
    10. Algeria
    11. Morocco
    12. Rest of Middle East & Africa
Competitive Landscape
1. List of Key Players and Their Offerings
2. Market Share Analysis, 2021
3. Competitive Benchmarking, By Operating Parameters
4. Key Strategic Development (Merger, Acquisition, Partnership, and others)
Impact of Covid-19 on Global Colorectal Cancer Therapeutics Market
Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
1. Accord Healthcare Ltd.
2. Amgen Inc.
3. Amneal Pharmaceuticals Inc.
4. Bayer AG
5. Biocon Ltd.
6. Bristol-Myers Squibb Co.
7. CK Hutchison Holdings Ltd.
8. Eli Lilly and Co.
9. F. Hoffmann La Roche Ltd.
10. Fresenius SE and Co. KGaA
11. Hetero Drugs Ltd.
12. Hikma Pharmaceuticals Plc
13. Merck and Co. Inc.
14. Ono Pharmaceutical Co. Ltd.
15. Otsuka Holdings Co. Ltd.
16. Pfizer Inc.
17. Sanofi SA
18. Sun Pharmaceutical Industries Ltd.
19. Teva Pharmaceutical Industries Ltd.
20. Viatris Inc.
21. Other prominent players

Key Strategic Recommendations

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

List of Figure

Figure 1 Global Colorectal Cancer Therapeutics Market Segmentation

Figure 2 Global Colorectal Cancer Therapeutics Value Chain Analysis

Figure 3 Company Market Share Analysis, 2021

Figure 4 Global Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 5 Global Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 7 Global Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 8 Global Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 9 Global Colorectal Cancer Therapeutics Market Share, By Region, By Value, 2018–2028

Figure 10 North America Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 11 North America Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 13 North America Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 14 North America Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 15 North America Colorectal Cancer Therapeutics Market Share, By Country, By Value, 2018–2028

Figure 16 United States Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 18 United States Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 19 United States Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 20 United States Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 21 Canada Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 23 Canada Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 24 Canada Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 25 Canada Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 26 Europe Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 27 Europe Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 29 Europe Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 30 Europe Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 31 Europe Colorectal Cancer Therapeutics Market Share, By Country, By Value, 2018–2028

Figure 32 Germany Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 34 Germany Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 35 Germany Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 36 Germany Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 37 UK Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 39 UK Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 40 UK Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 41 UK Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 42 Italy Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 44 Italy Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 45 Italy Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 46 Italy Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 47 France Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 49 France Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 50 France Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 51 France Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 52 Spain Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 54 Spain Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 55 Spain Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 56 Spain Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 57 The Netherlands Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 59 The Netherlands Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 60 The Netherlands Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 61 The Netherlands Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 62 Belgium Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 64 Belgium Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 65 Belgium Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 66 Belgium Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 67 NORDIC Countries Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 69 NORDIC Countries Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 70 NORDIC Countries Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 71 NORDIC Countries Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 72 Rest of Europe Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 74 Rest of Europe Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 75 Rest of Europe Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 76 Rest of Europe Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 77 Asia-Pacific Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 78 Asia-Pacific Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 80 Asia-Pacific Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 81 Asia-Pacific Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 82 Asia-Pacific Colorectal Cancer Therapeutics Market Share, By Country, By Value, 2018–2028

Figure 83 China Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 85 China Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 86 China Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 87 China Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 88 India Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 90 India Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 91 India Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 92 India Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 93 Japan Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 95 Japan Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 96 Japan Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 97 Japan Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 98 South Korea Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 100 South Korea Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 101 South Korea Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 102 South Korea Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 103 Australia & New Zealand Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 105 Australia & New Zealand Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 106 Australia & New Zealand Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 107 Australia & New Zealand Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 108 Indonesia Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 110 Indonesia Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 111 Indonesia Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 112 Indonesia Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 113 Malaysia Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 115 Malaysia Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 116 Malaysia Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 117 Malaysia Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 118 Singapore Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 120 Singapore Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 121 Singapore Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 122 Singapore Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 123 Philippines Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 125 Philippines Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 126 Philippines Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 127 Philippines Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 128 Vietnam Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 130 Vietnam Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 131 Vietnam Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 132 Vietnam Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 133 Rest of Asia Pacific Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 135 Rest of Asia Pacific Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 136 Rest of Asia Pacific Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 137 Rest of Asia Pacific Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 138 Latin America Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 139 Latin America Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 141 Latin America Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 142 Latin America Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 143 Latin America Colorectal Cancer Therapeutics Market Share, By Country, By Value, 2018–2028

Figure 144 Brazil Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 146 Brazil Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 147 Brazil Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 148 Brazil Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 149 Mexico Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 151 Mexico Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 152 Mexico Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 153 Mexico Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 154 Argentina Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 156 Argentina Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 157 Argentina Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 158 Argentina Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 159 Peru Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 161 Peru Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 162 Peru Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 163 Peru Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 164 Colombia Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 166 Colombia Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 167 Colombia Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 168 Colombia Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 169 Rest of Latin America Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 171 Rest of Latin America Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 172 Rest of Latin America Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 173 Rest of Latin America Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 174 Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 175 Middle East & Africa Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 177 Middle East & Africa Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 178 Middle East & Africa Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 179 Middle East & Africa Colorectal Cancer Therapeutics Market Share, By Country, By Value, 2018–2028

Figure 180 Saudi Arabia Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 182 Saudi Arabia Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 183 Saudi Arabia Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 184 Saudi Arabia Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 185 UAE Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 187 UAE Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 188 UAE Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 189 UAE Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 190 Qatar Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 192 Qatar Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 193 Qatar Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 194 Qatar Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 195 Kuwait Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 197 Kuwait Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 198 Kuwait Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 199 Kuwait Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 200 Iran Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 202 Iran Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 203 Iran Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 204 Iran Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 205 South Africa Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 207 South Africa Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 208 South Africa Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 209 South Africa Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 210 Nigeria Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 212 Nigeria Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 213 Nigeria Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 214 Nigeria Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 215 Kenya Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 217 Kenya Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 218 Kenya Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 219 Kenya Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 220 Egypt Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 222 Egypt Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 223 Egypt Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 224 Egypt Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 225 Morocco Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 227 Morocco Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 228 Morocco Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 229 Morocco Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 230 Algeria Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 232 Algeria Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 233 Algeria Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 234 Algeria Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 235 Rest of Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 236 Rest of Middle East & Africa Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 237 Rest of Middle East & Africa Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 238 Rest of Middle East & Africa Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

List of Tables

Table 1 Global Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 2 Global Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 3 Global Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 4 North America Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 5 North America Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 7 North America Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 8 North America Colorectal Cancer Therapeutics Market Size, By Country, By Value, 2018–2028

Table 9 United States Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 10 United States Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 11 United States Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 13 Canada Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 14 Canada Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 15 Canada Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 16 Europe Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 18 Europe Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 19 Europe Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 20 Europe Colorectal Cancer Therapeutics Market Size, By Country, By Value, 2018–2028

Table 21 Germany Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 23 Germany Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 24 Germany Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 25 UK Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 26 UK Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 27 UK Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 29 Italy Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 30 Italy Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 31 Italy Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 32 France Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 33 France Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 34 France Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 35 Spain Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 36 Spain Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 37 Spain Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 38 The Netherlands Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 39 The Netherlands Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 40 The Netherlands Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 41 Belgium Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 42 Belgium Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 43 Belgium Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 44 NORDIC Countries Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 45 NORDIC Countries Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 46 NORDIC Countries Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 47 Rest of Europe Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 48 Rest of Europe Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 49 Rest of Europe Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 50 Asia-Pacific Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 51 Asia-Pacific Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 52 Asia-Pacific Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 53 Asia-Pacific Colorectal Cancer Therapeutics Market Size, By Country, By Value, 2018–2028

Table 54 China Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 55 China Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 56 China Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 57 India Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 58 India Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 59 India Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 60 Japan Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 61 Japan Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 62 Japan Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 63 South Korea Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 64 South Korea Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 65 South Korea Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 66 Australia & New Zealand Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 67 Australia & New Zealand Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 68 Australia & New Zealand Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 69 Indonesia Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 70 Indonesia Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 71 Indonesia Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 72 Malaysia Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 73 Malaysia Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 74 Malaysia Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 75 Singapore Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 76 Singapore Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 77 Singapore Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 78 Philippines Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 79 Philippines Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 80 Philippines Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 81 Vietnam Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 82 Vietnam Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 83 Vietnam Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 84 Rest of Asia Pacific Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 85 Rest of Asia Pacific Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 86 Rest of Asia Pacific Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 87 Latin America Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 88 Latin America Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 89 Latin America Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 90 Latin America Colorectal Cancer Therapeutics Market Size, By Country, By Value, 2018–2028

Table 91 Brazil Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 92 Brazil Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 93 Brazil Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 94 Mexico Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 95 Mexico Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 96 Mexico Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 97 Argentina Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 98 Argentina Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 99 Argentina Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 100 Peru Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 101 Peru Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 102 Peru Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 103 Colombia Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 104 Colombia Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 105 Colombia Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 106 Rest of Latin America Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 107 Rest of Latin America Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 108 Rest of Latin America Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 109 Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 110 Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 111 Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 112 Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Country, By Value, 2018–2028

Table 113 Saudi Arabia Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 114 Saudi Arabia Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 115 Saudi Arabia Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 116 UAE Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 117 UAE Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 118 UAE Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 119 Qatar Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 120 Qatar Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 121 Qatar Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 122 Kuwait Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 123 Kuwait Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 124 Kuwait Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 125 Iran Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 126 Iran Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 127 Iran Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 128 South Africa Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 129 South Africa Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 130 South Africa Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 131 Nigeria Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 132 Nigeria Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 133 Nigeria Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 134 Kenya Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 135 Kenya Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 136 Kenya Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 137 Egypt Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 138 Egypt Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 139 Egypt Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 140 Morocco Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 141 Morocco Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 142 Morocco Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 143 Algeria Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 144 Algeria Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 145 Algeria Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 146 Rest of Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 147 Rest of Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 148 Rest of Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 149 Accord Healthcare Ltd. Company Overview

Table 150 Accord Healthcare Ltd. Financial Overview

Table 151 Amgen Inc. Company Overview

Table 152 Amgen Inc. Financial Overview

Table 153 Amneal Pharmaceuticals Inc. Company Overview

Table 154 Amneal Pharmaceuticals Inc. Financial Overview

Table 155 Bayer AG Company Overview

Table 156 Bayer AG Financial Overview

Table 157 Biocon Ltd. Company Overview

Table 158 Biocon Ltd. Financial Overview

Table 159 Bristol-Myers Squibb Co. Company Overview

Table 160 Bristol-Myers Squibb Co. Financial Overview

Table 161 CK Hutchison Holdings Ltd. Company Overview

Table 162 CK Hutchison Holdings Ltd. Financial Overview

Table 163 Eli Lilly and Co. Company Overview

Table 164 Eli Lilly and Co. Financial Overview

Table 165 F. Hoffmann La Roche Ltd. Company Overview

Table 166 F. Hoffmann La Roche Ltd. Financial Overview

Table 167 Fresenius SE and Co. KGaA Company Overview

Table 168 Fresenius SE and Co. KGaA Financial Overview

Table 169 Hetero Drugs Ltd. Company Overview

Table 170 Hetero Drugs Ltd. Financial Overview

Table 171 Hikma Pharmaceuticals Plc Company Overview

Table 172 Hikma Pharmaceuticals Plc Financial Overview

Table 173 Merck and Co. Inc. Company Overview

Table 174 Merck and Co. Inc. Financial Overview

Table 175 Ono Pharmaceutical Co. Ltd. Company Overview

Table 176 Ono Pharmaceutical Co. Ltd. Financial Overview

Table 177 Otsuka Holdings Co. Ltd. Company Overview

Table 178 Otsuka Holdings Co. Ltd. Financial Overview

Table 179 Pfizer Inc. Company Overview

Table 180 Pfizer Inc. Financial Overview

Table 181 Sanofi SA Company Overview

Table 182 Sanofi SA Financial Overview

Table 183 Sun Pharmaceutical Industries Ltd. Company Overview

Table 184 Sun Pharmaceutical Industries Ltd. Financial Overview

Table 185 Teva Pharmaceutical Industries Ltd. Company Overview

Table 186 Teva Pharmaceutical Industries Ltd. Financial Overview

Table 187 Viatris Inc. Company Overview

Table 188 Viatris Inc. Financial Overview

Market Segmentation

By Therapy

Target Therapy
Immunotherapy
Chemotherapy
Others

By Cancer Type

Colorectal Adenocarcinoma
Gastrointestinal Carcinoid Tumors
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

By Region

- - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Yes, I have read the privacy policy

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

1. Which region is the dominant one in Global Colorectal Cancer Therapeutics Market?

Ans: North America holds the highest share in Global Colorectal Cancer Therapeutics Market.

2. What is the current size of the Global Colorectal Cancer Therapeutics Market?

Ans: Global Colorectal Cancer Therapeutics Market size reached a value USD 12.38 billion in 2021.

3. What are the major factors driving the growth of the Global Colorectal Cancer Therapeutics Market?

Ans: Major growth factors for Global Colorectal Cancer Therapeutics Market include high incident and mortality rates of colorectal cancer across the world and increasing awareness about the disease and therapeutics.

4. Name the key players in the Global Colorectal Cancer Therapeutics Market.

Ans: Key players in Global Colorectal Cancer Therapeutics Market include Accord Healthcare Ltd., Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Biocon Ltd., Bristol-Myers Squibb Co., CK Hutchison Holdings Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hetero Drugs Ltd., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.

PLACE AN ORDER

SINGLE USER LICENSE
$ 4450
GROUP LICENSE
$ 5550
ENTERPRISE LICENSE
$ 7850

Request for Sample

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Custom Research Service

Ask the Analyst to customize an exclusive study to serve your research needs
Quality & Accuracy

Ask the Analyst to customize an exclusive study to serve your research needs
Data Visualization

As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.